Novavax Inc (NVAX) Stock Price, Quote & News

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 268 2000

Website: www.novavax.com

Address:

21 Firstfield Road, Gaithersburg, United States

upgrayeddd Jul. 4 at 7:10 PM

$NVAX weekly close above the 200w ma twice the past month, after zero such closes since 2022. Jacobs continues to right the ship.

0 · Reply

ChannelGuru Jul. 4 at 5:23 AM

$NVAX Happy 4th July to my brother Bulls across the pond. Enjoy the long weekend with your families, friends..

2 · Reply

Trader00995 Jul. 4 at 5:22 AM

$NVAX hey , hantavirus finish already? I thought it is a big deal..)

3 · Reply

Kikii2 Jul. 3 at 10:56 PM

$NVAX Sorry guys the Sanofi references should have said Novavax.

1 · Reply

kwinters71 Jul. 3 at 10:32 PM

$NVAX off topic, but I love during FIFA seeing all of the people from around the world coming to America and realizing how great this country is and that we’re just cool normal people and we like them and they like us, Yexas guy here

4 · Reply

Kikii2 Jul. 3 at 9:47 PM

$NVAX SII (Serum Institute of India) CIC phase 3 trial modification. The India regulators have asked for modification to the phase 3 CIC trial they will be conducting before granting final approval. This CIC is identical to the CIC Novavax currently has on the shelf waiting for a partner. One can see the changes requested in the study via the attached link. Interesting however, is they conducted this study using 2100 patients in Australia and New Zealand. This is the same patient amount that has been stated on this board as being the Sanofi study NCT06291857 that some believe was cut short. The Sanofi study clearly states 9320 participants. Maybe this is where the confusion is coming from. https://medicaldialogues.in/news/industry/pharma/cdsco/cdsco-asks-serum-institute-to-revise-protocol-for-trivalent-flu-covid-vaccine-trial-150748

2 · Reply

andy4343 Jul. 3 at 8:53 PM

$NVAX A mixtape from Shah Capital Records always worked better for me than flowers ever did. I know from experience....if you know what I mean. https://x.com/the43rdcaptain/status/2073147415536803888?s=46

1 · Reply

Biotechlineup Jul. 3 at 5:29 PM

$NVAX I have been on the Moderna board giving them a dose of reality on why almost the entire pipeline will fail and why I’m absolutely convinced of matrix m potential. Many posts not going to repeat here. For Novavax Lysosomal Membrane Permeabilization (LMP). That’s all you really have to know. That’s it in a nutshell . Once that was proven it just became the most valuable biotech asset on Earth. Just about works with everything from infectious disease to oncology. Secret sauce, magic m , holy grail, intel inside. Like salt sprinkle it in and somehow makes almost every food taste better. From university backed private companies with 2 nd generation mRNA like iOncologi,to rivals like BioNTech , giants like Merck and Pfizer to the smallest microcaps like Bctx. I was seriously trash talking Moderna, however you know Moderna 4359 would really benefit from matrix m as well. Really incredible would make it a blockbuster with Merck’s Keytruda which has really been used up.

2 · Reply

Flowdollas777 Jul. 3 at 4:52 PM

$NVAX I'm so invested in Matrix M that when Moderna went down to the $20's, I purposely didn't invest!!.🤪 I hate mRNA so much that I chose to lose money!!🤣 It's apparent the powers that be behind mRNA wield a very heavy hand. POTUS finally caved, flipped the switch, canned the whole FDA big wigs and reduced RFK to a silent puppeteer. Nevertheless,... I patiently wait for Matrix M to pay up. Meanwhile... mRNA & Crypto will continue to manipulate the market and make billions for the powers that be. 🤨

2 · Reply

StreakGeek Jul. 3 at 4:50 PM

Banked from @TopSarge alerts the last few weeks, timing’s been on point! Follow him so you don't miss out 🔥 $TE $NVAX $RYCEY take your pick all good

0 · Reply

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

2026-06-22T15:15:08.000Z - 12 days ago

Novavax put volume heavy and directionally bearish

Jun 18, 2026, 8:30 AM EDT - 16 days ago

Novavax Transcript: AGM 2026

Jun 4, 2026, 10:30 AM EDT - 4 weeks ago

Novavax Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 4:00 PM EDT - 4 weeks ago

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

May 13, 2026, 6:40 PM EDT - 7 weeks ago

Novavax Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 7:00 AM EDT - 7 weeks ago

Novavax Slides: Corporate presentation

May 11, 2026, 7:53 AM EDT - 7 weeks ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO MRNA

May 7, 2026, 4:00 PM EDT - 2 months ago

Novavax to Participate in BofA Securities 2026 Health Care Conference

2026-05-07T06:32:47.000Z - 2 months ago

Novavax reports Q1 EPS (6c), consensus (23c)

2026-05-07T05:08:24.000Z - 2 months ago

Novavax price target raised to $9 from $8 at TD Cowen

SNY

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

May 6, 2026, 7:56 AM EDT - 2 months ago

Novavax beats first-quarter revenue estimates on vaccine deals strength

Apr 29, 2026, 4:00 PM EDT - 2 months ago

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Novavax Proxy statement: Proxy filing

2026-04-09T14:00:15.000Z - 3 months ago

Novavax price target raised to $18 from $16 at B. Riley

Apr 8, 2026, 6:08 AM EDT - 3 months ago

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Mar 30, 2026, 8:00 AM EDT - 3 months ago

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 10, 2026, 3:40 PM EDT - 4 months ago

Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 2:30 PM EST - 4 months ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 4:30 PM EST - 4 months ago

Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Slides: Q4 2025

Feb 26, 2026, 8:06 AM EST - 4 months ago

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Feb 26, 2026, 8:00 AM EST - 4 months ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Feb 19, 2026, 8:00 AM EST - 4 months ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 20, 2026, 7:15 AM EST - 5 months ago

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:11 AM EST - 5 months ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Jan 14, 2026, 7:30 PM EST - 6 months ago

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 6 months ago

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 6 months ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 1, 2025, 3:50 PM EST - 7 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Dec 1, 2025, 12:35 PM EST - 7 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Dec 1, 2025, 9:59 AM EST - 7 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Nov 19, 2025, 11:30 AM EST - 8 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 4:41 PM EST - 8 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 8:00 AM EST - 8 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 7:58 AM EST - 8 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 4, 2025, 7:00 AM EST - 8 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Oct 30, 2025, 8:00 AM EDT - 8 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 7:00 AM EDT - 9 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 14, 2025, 6:09 AM EDT - 9 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 7, 2025, 7:00 AM EDT - 9 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Sep 30, 2025, 9:01 AM EDT - 9 months ago

Novavax Announces Progress on Sanofi Agreement

Sep 19, 2025, 11:40 AM EDT - 10 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Sep 4, 2025, 10:20 AM EDT - 10 months ago

Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 10 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 3, 2025, 8:00 AM EDT - 10 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Aug 27, 2025, 3:07 PM EDT - 11 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 21, 2025, 7:43 AM EDT - 11 months ago

Novavax Announces Convertible Debt Refinancing

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Slides: Q2 2025

Aug 6, 2025, 8:08 AM EDT - 11 months ago

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:00 AM EDT - 11 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Slides: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 7:11 AM EDT - 1 year ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 10, 2025, 10:45 AM EDT - 1 year ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Jun 10, 2025, 8:18 AM EDT - 1 year ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

May 20, 2025, 4:34 PM EDT - 1 year ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

May 19, 2025, 9:27 AM EDT - 1 year ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 7:16 AM EDT - 1 year ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:00 AM EDT - 1 year ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 17, 2025, 10:26 PM EDT - 1 year ago

FDA approves Novavax COVID vaccine with new conditions

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Slides: FY 2025

May 8, 2025, 11:12 AM EDT - 1 year ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

upgrayeddd Jul. 4 at 7:10 PM

$NVAX weekly close above the 200w ma twice the past month, after zero such closes since 2022. Jacobs continues to right the ship.

0 · Reply

ChannelGuru Jul. 4 at 5:23 AM

$NVAX Happy 4th July to my brother Bulls across the pond. Enjoy the long weekend with your families, friends..

2 · Reply

Trader00995 Jul. 4 at 5:22 AM

$NVAX hey , hantavirus finish already? I thought it is a big deal..)

3 · Reply

Kikii2 Jul. 3 at 10:56 PM

$NVAX Sorry guys the Sanofi references should have said Novavax.

1 · Reply

kwinters71 Jul. 3 at 10:32 PM

4 · Reply

Kikii2 Jul. 3 at 9:47 PM

2 · Reply

andy4343 Jul. 3 at 8:53 PM

1 · Reply

Biotechlineup Jul. 3 at 5:29 PM

2 · Reply

Flowdollas777 Jul. 3 at 4:52 PM

2 · Reply

StreakGeek Jul. 3 at 4:50 PM

Banked from @TopSarge alerts the last few weeks, timing’s been on point! Follow him so you don't miss out 🔥 $TE $NVAX $RYCEY take your pick all good

0 · Reply

Eternalpatience1 Jul. 3 at 2:34 PM

$NVAX Sanofu didn't move this. Pfizer deal didn't move this. We are still under 10. What the heck will move this fuck out of the 10s

4 · Reply

wintogether Jul. 3 at 2:08 PM

$NVAX another question: why did JJ, Dr. Walker and Kelly not get any of the stocks distributed to the insiders recently?

1 · Reply

Ochayethenoo Jul. 3 at 12:27 PM

$NVAX As I understand it, July 4th is the day when Americans dismount from their ponies, then take the feathers out of their hats and make a pasta dish out of it.

1 · Reply

Chelsea100 Jul. 3 at 11:52 AM

$NVAX hey, villa bacho, america closed today. next monday you can come. today you stay at home ombre, capice...

1 · Reply

Benroxx Jul. 3 at 11:21 AM

$NVAX Why closed today?

1 · Reply

Ilikethestock89 Jul. 3 at 9:45 AM

$NVAX that feel moderna is 80 amd this turdie cant go above 10 stabil

0 · Reply

Lacocchi Jul. 3 at 9:02 AM

$NVAX ma oggi è aperta la borsa usa?

1 · Reply

PapiMegachullo Jul. 3 at 9:00 AM

$NVAX Happy 4th of July to all my fellow American longs! You are all a real American Heroes to me - the real deal, tough guys and gals Triple digits here we come! :)

3 · Reply

BTC321 Jul. 3 at 8:09 AM

$NVAX $MRNA let's do this! COME ON!

1 · Reply

Kawasaki1 Jul. 3 at 4:52 AM

$NVAX The Most Upside of ANY stock in the Market.

1 · Reply

DragonTiger Jul. 3 at 3:34 AM

$NVAX has the most anti-shareholder value CEO, aka mfker JJ in charge. So, I will be more than happy if this POS could get to 15 this year so that I would dump it

1 · Reply

Paulchowda Jul. 2 at 11:12 PM

$NVAX one last one, who the hell is doing the data for Moderna? I was just reading some stuff and it just doesn’t add up, our boy from Canada posted about 100 people dying during the trial probably more, just remember mRNA is toxic as hell why are they just letting this shit go??? guessing they just wanna get rid of the elderly population…

1 · Reply

Market Cap	1.60B
Revenue (ttm)	1.12B
Net Income (ttm)	440.30M
EPS (ttm)	N/A
PE Ratio	189.20
Forward PE	N/A
Profit Margin	39.19%
Debt to Equity Ratio	-2.01

Volume	4,850,700
Avg Vol	5,188,368
Day's Range	N/A - N/A
Shares Out	164.44M
Stochastic %K	80%
Beta	2.43
Analysts	Sell
Price Target	$13.70